18 a 19 Sep. 2024
CIMT Cancer Cell Therapy Summit
Hosted by the Champalimaud Foundation
September 18-19, 2024
Lisbon, Portugal
18 a 19 Sep. 2024
Hosted by the Champalimaud Foundation
September 18-19, 2024
Lisbon, Portugal
This meeting collaboration between the Association for Cancer Immunotherapy CIMT and the Champalimaud Foundation will address promising paths towards effective cellular treatment modalities for patients with solid cancer and discuss the boundaries of synthetically engineered immune cells. The meeting will also discuss the innovation gap between academic and small biotech driven research, and the challenges of safe, biologically, and clinically relevant phase I / II clinical trials.
The summit sessions will offer a patient-focused perspective on cell therapy possibilities by addressing the quality and nature of the “cellular product” as the starting material for cell therapy; patient-specific therapy and product development including molecular engineering; longevity and “fitness” of cell products after adoptive transfer, and mobilization of autologous anti-cancer directed T-cell responses.
Confirmed speakers include: Mark Yarmarkovich (New York University), Sebastian Klobuch (Netherlands Cancer Institute), Davide Bedognetti (Kite Pharma), Sebastian Kobold (University Medical Center of Munich), Mirjam Heemskerk (Leiden University Medical Center), Stanley Qi (Stanford University), Tal Danino (Columbia University), Andreas Mackensen (University Hospital Erlangen), Judith Kroep (Leiden University Medical Center), Christian Blank (Netherlands Cancer Institute), Jason Bock (CTMC/MD Anderson Cancer Center), Marie Henriksson (Karolinska Institutet), Cécile Alanio (Curie Institute).
The CIMT Cell Therapy Summit will take place at the Champalimaud Foundation in Lisbon.
Address: Avenida Brasília, 400-038 Lisbon - Portugal
Click HERE to register.
To know more about the ticket fees, follow this link.
Registration is free for researchers, students and academia.
If you encounter any problem during the registration process, please contact our registration support at hello@beamian.com. For further information, please write to office@cimt.eu
Franco Marincola, Christoph Huber, Kees Melief, Dolores Schendel, Özlem Türeci, Alexander Eggermont, Markus Maeurer